Status:
UNKNOWN
Impact of Catecholamine Spill-over on Outcome After RDN and EP Ablation
Lead Sponsor:
University of Witten/Herdecke
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
Despite a rapidly increasing number of renal denervation (RDN) procedures, only little is known regarding the patient or procedural characteristics influencing the outcome. None of the detectable vari...
Eligibility Criteria
Inclusion
- medically-indicated renal denervation
- Age over 18 years
- written informed consent
Exclusion
- pregnancy
- expected compliance problems
- current participation in other studies
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01875809
Start Date
March 1 2013
Last Update
June 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HELIOS Klinikum
Wuppertal, North Rhine-Westphalia, Germany, 42117